A major food and drug administration advisory panel will review and vote on Johnson & Johnson’s single-vaccine Covid-19 vaccine on Friday, which could pave the way for an emergency authorization in the coming days. If approved, the J&J survey is the third to be made available in the US and is distributed through a relatively simple supply chain: the one-dose regimens the need to detect return visits, and the drug can extreme temperatures are stored. as vaccines made by Pfizer and Moderna. The influx of supply and simplified logistics are likely to give an immediate boost to national vaccination rates when the vaccine hits the market as early as next week.
The U.S. records at least 73,300 new Covid-19 cases each day and at least 2,160 virus-related deaths, based on a seven-day average calculated by CNBC using Johns Hopkins University data.
The following data were compiled by Johns Hopkins University:
- Global affairs: More than 113.08 million
- World deaths: At least 2.5 million
- US affairs: More than 28.41 million
- U.S. Deaths: At least 508,314